 |
Sucralfate suspension |
|---|---|
| Trade Name | |
| Orphan Indication | Oral ulcerations and dysphagia in patients with epidermolysis bullosa |
| USA Market Approval | USA |
| USA Designation Date | 1991-03-04 00:00:00 |
| Sponsor | Darby Pharmaceuticals, Inc.;100 Banks Avenue;Rockville Centre, New York, 11570 |
